DSP expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.398400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.230200E-01
Normal-vs-Stage2
5.876600E-01
Normal-vs-Stage3
5.819200E-01
Normal-vs-Stage4
4.349400E-01
Stage1-vs-Stage2
6.224400E-01
Stage1-vs-Stage3
5.441400E-01
Stage1-vs-Stage4
1.852410E-01
Stage2-vs-Stage3
5.202800E-01
Stage2-vs-Stage4
6.378000E-03
Stage3-vs-Stage4
1.213200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.565000E-01
Normal-vs-AfricanAmerican
8.475000E-01
Normal-vs-Asian
5.626600E-01
Caucasian-vs-AfricanAmerican
9.531600E-01
Caucasian-vs-Asian
3.759800E-01
AfricanAmerican-vs-Asian
5.934600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.723000E-01
Normal-vs-Female
7.112800E-01
Male-vs-Female
7.421200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.645000E-01
Normal-vs-Age(41-60Yrs)
8.960400E-01
Normal-vs-Age(61-80Yrs)
5.920600E-01
Normal-vs-Age(81-100Yrs)
8.687000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.911600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.479200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.989600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.893190E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.923800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.230400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.162000E-01
Normal-vs-Daily Drinker
6.322000E-01
Normal-vs-Weekly Drinker
5.023400E-01
Normal-vs-Occasional Drinker
5.653800E-01
Normal-vs-Social Drinker
8.381200E-01
Non Drinker-vs-Daily Drinker
1.213800E-01
Non Drinker-vs-Weekly Drinker
3.446400E-01
Non Drinker-vs-Occasional Drinker
5.984400E-02
Non Drinker-vs-Social Drinker
9.293400E-01
Daily Drinker-vs-Weekly Drinker
7.184800E-01
Daily Drinker-vs-Occasional Drinker
8.003200E-03
Daily Drinker-vs-Social Drinker
1.020440E-01
Weekly Drinker-vs-Occasional Drinker
3.254200E-02
Weekly Drinker-vs-Social Drinker
3.023600E-01
Occasional Drinker-vs-Social Drinker
1.073160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.457800E-02
Normal-vs-Grade 2
1.271510E-02
Normal-vs-Grade 3
5.996900E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.137400E-01
Grade 1-vs-Grade 3
9.167000E-01
Grade 1-vs-Grade 4
4.457800E-02
Grade 2-vs-Grade 3
3.744200E-02
Grade 2-vs-Grade 4
1.271510E-02
Grade 3-vs-Grade 4
5.996900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.934400E-01
Normal-vs-NonDiabetic
7.811200E-01
Diabetic-vs-NonDiabetic
3.238600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.716200E-01
Normal-vs-NoPancreatitis
7.781800E-01
Pancreatitis-vs-NoPancreatitis
3.746800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.880000E-01
Normal-vs-N1
6.353800E-01
N0-vs-N1
1.183160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.499000E-01
Normal-vs-TP53-NonMutant
8.557200E-01
TP53-Mutant-vs-TP53-NonMutant
7.151800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
